Does SUTENT Cause Second primary malignancy? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Second primary malignancy have been filed in association with SUTENT. This represents 1.3% of all adverse event reports for SUTENT.
16
Reports of Second primary malignancy with SUTENT
1.3%
of all SUTENT reports
5
Deaths
4
Hospitalizations
How Dangerous Is Second primary malignancy From SUTENT?
Of the 16 reports, 5 (31.3%) resulted in death, 4 (25.0%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUTENT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SUTENT Cause?
Disease progression (226)
Death (225)
Diarrhoea (164)
Fatigue (140)
Nausea (119)
Decreased appetite (78)
Vomiting (73)
Asthenia (67)
Oral pain (66)
Dysgeusia (63)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which SUTENT Alternatives Have Lower Second primary malignancy Risk?
SUTENT vs SUTIMLIMAB-JOME
SUTENT vs SUVOREXANT
SUTENT vs SUZETRIGINE
SUTENT vs SYMBICORT
SUTENT vs SYNAGIS